Profiling Cancer Biology™ with Ultivue – New in Eldan

Eldan announced new partnership with Ultivue in Israel!
Ultivue is an innovative reagent-based solution that maximizes the biological information available from cells and tissue samples.

Ultivue’s technology is being used to elucidate biological pathways and validate clinically-relevant biomarkers and provides researchers and scientists with multiplex biomarker assays, for tissue phenotyping and digital pathology.

Ultivue’s proprietary InSituPlex® technology enables advanced exploration and interrogation of tissue samples for precision medicine research.

Please contact Eldan’s Bio-Team for details.

Visit Ultivue’s website >>

Home | About Us | Medical Division | Life Science Division | Our Partners | Careers | Newsroom | Legal Notice

All Rights reserved, Neopharm Group, Israel | Design by: VAZA | Developed by: The Shark Lady